Work

Power in Numbers: Meta-analysis to Identify Inhibitor-Sensitive Tumor Genotypes

Year: 2013

Type: article

Abstract: Widespread tumor genotyping has increased the complexity of lung cancer care, often identifying mutations of uncertain clinical significance. In the accompanying article, the authors carried out a meta-analysis of the published literature on EGF receptor (EGFR) genotype and erlotinib/gefitinib sensitivity to develop a publicly accessible database to inform patient care.

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-13-0169

Authors: Geoffrey R. Oxnard, Pasi A. Jänne

Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute